REVVITY, INC Debt Securities, Available-for-sale
REVVITY, INC (RVTY) had Debt Securities, Available-for-sale of $12.34 million as of 2024-12-29, per its 10-K filed 2025-02-25.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-02-25
- 2024-12-29: Debt Securities, Available-for-sale $12.34M.
- 2023-12-31: Debt Securities, Available-for-sale $12.28M.
- 2023-01-01: Debt Securities, Available-for-sale $42.50M.
- 2022-01-02: Debt Securities, Available-for-sale $13.50M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-12-29 | $12.34M 10-K · filed 2025-02-25 |
| 2023-12-31 | $12.28M 10-K · filed 2025-02-25 |
| 2023-01-01 | $42.50M 10-K · filed 2024-02-27 |
| 2022-01-02 | $13.50M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |